CIK 0001531177
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800625749
- Phone
- +1 415-889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- 4 Open-market sale Chief Financial Officer sold 4,999 shares at an average $7.78 ($38,890)
- 4 Open-market sale Chief Operating Officer sold 20,543 shares at an average $7.66 ($157,366)
- 4 Open-market sale EVP, Operations & R&D sold 619 shares at $7.48 ($4,630)
- 4 Option exercise Chief Technology Officer acquired 21,270 shares (option exercise)
- 4/A Derivatives Options or other derivatives
- 4 Open-market buy Director bought 13,958 shares at $8.31 ($115,963)
- 4 Open-market sale Chief Financial Officer sold 2,518 shares at $8.25 ($20,774)
- 4 Planned sale Chief Legal Officer sold 44,850 shares at $8.08 ($362,388)
- 4 Open-market sale EVP, Operations & R&D sold 14,418 shares at $7.06 ($101,791)
- 4 Planned sale Chief Legal Officer sold 3,150 shares at $8.01 ($25,232)
- 4 Grant or award Chief Operating Officer acquired 23,006 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 15,337 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, Operations & R&D sold 591 shares at $3.37 ($1,992)
- 4 Open-market sale Chief Financial Officer sold 19,948 shares at $3.30 ($65,828)
- 4 Open-market sale President and CEO sold 24,441 shares at $3.34 ($81,633)
- 4 Open-market sale Chief Technology Officer sold 6,033 shares at $3.27 ($19,728)
- 4 Open-market sale Chief Legal Officer sold 9,731 shares at $3.27 ($31,820)
- 4 Gift Director gave 37,492 shares (gift)
- 4 Grant or award EVP, Operations & R&D acquired 25,840 shares (grant or award)
Page 3 of 12 · 225 filings